Period Ending | Dec 31, 2011 | Sep 30, 2011 | Jun 30, 2011 | Mar 31, 2011 |
---|
Total Revenue
|
3,517,000
|
3,849,000
|
3,986,000
|
3,533,000
| Cost of Revenue | 2,184,000 | 2,353,000 | 2,417,000 | 2,127,000 | |
Gross Profit
|
1,333,000
|
1,496,000
|
1,569,000
|
1,406,000
| |
|
Operating Expenses |
|
Research Development | 109,000 | 108,000 | 110,000 | 103,000 |
|
Selling General and Administrative | 802,000 | 806,000 | 829,000 | 797,000 |
|
Non Recurring | 3,000 | 3,000 | 3,000 | 3,000 |
|
Others | 115,000 | 116,000 | 119,000 | 117,000 |
|
|
|
Total Operating Expenses | 1,029,000 | 1,033,000 | 1,061,000 | 1,020,000 | | |
Operating Income or Loss
|
304,000
|
463,000
|
508,000
|
386,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 31,000 | 50,000 | 47,000 | 18,000 |
|
Earnings Before Interest And Taxes | 335,000 | 513,000 | 555,000 | 404,000 |
|
Interest Expense | 51,000 | 51,000 | 55,000 | 53,000 |
|
Income Before Tax | 284,000 | 462,000 | 500,000 | 351,000 |
|
Income Tax Expense | 45,000 | 120,000 | 128,000 | 92,000 |
|
Minority Interest | (23,000) | (31,000) | (32,000) | (31,000) |
|
|
|
Net Income From Continuing Ops | 216,000 | 311,000 | 340,000 | 228,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
216,000
|
311,000
|
340,000
|
228,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
216,000
|
311,000
|
340,000
|
228,000
|
|